HomeBCLI • OTCMKTS
Brainstorm Cell Therapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.05M | -32.84% |
Net income | -2.11M | 22.23% |
Net profit margin | — | — |
Earnings per share | -0.19 | 62.75% |
EBITDA | -2.00M | 33.22% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.00K | -97.02% |
Total assets | 1.38M | -31.85% |
Total liabilities | 9.07M | 12.26% |
Total equity | -7.69M | — |
Shares outstanding | 11.03M | — |
Price to book | -0.89 | — |
Return on assets | -259.38% | — |
Return on capital | 80.30% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -2.11M | 22.23% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
$0.62
Day range
$0.60 - $0.67
Year range
$0.52 - $2.50
Market cap
6.79M USD
Avg Volume
16.65K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
About
Founded
2000
Website
Employees
29
